The mechanism of Tat-enhanced reverse transcription in HIV-1

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

During reverse transcription, the positive-strand HIV-1 RNA genome is converted into a double-stranded DNA copy which can be permanently insert into the host cell genome. Many HIV-1 proteins including Tat contribute to the efficiency of reverse transcription. There are two competing hypotheses to explain how Tat enhances reverse transcription. The indirect mechanism hypothesis holds that Tat-enhanced reverse transcription is due to the combined effects of the Tat-induced expression of cellular genes. The direct mechanism hypothesis is that Tat functions directly during RTN, implying it is a virion protein. Our recent genetic and biochemical data provide strong evidence that a novel form of Tat, which we call vTat, has a direct role in RTN. This proposal will investigate these two leading hypotheses. Given the enormity of the HIV pandemic and the many recent reports from the United States that most patient isolated virus is resistant to at least one antiretroviral drug, these studies have as an outcome the identification and characterisation of important new key molecules towards which antiretroviral strategies can be designed.

Funded Activity Details

Start Date: 01-01-2003

End Date: 01-01-2005

Funding Scheme: NHMRC Project Grants

Funding Amount: $282,750.00

Funder: National Health and Medical Research Council